A detailed history of Snyder Capital Management L P transactions in Bio Techne Corp stock. As of the latest transaction made, Snyder Capital Management L P holds 1,063,790 shares of TECH stock, worth $77.8 Million. This represents 1.85% of its overall portfolio holdings.

Number of Shares
1,063,790
Previous 1,003,691 5.99%
Holding current value
$77.8 Million
Previous $71.9 Million 18.21%
% of portfolio
1.85%
Previous 1.67%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$70.96 - $82.35 $4.26 Million - $4.95 Million
60,099 Added 5.99%
1,063,790 $85 Million
Q2 2024

Aug 14, 2024

SELL
$62.12 - $84.15 $1.18 Million - $1.59 Million
-18,929 Reduced 1.85%
1,003,691 $71.9 Million
Q1 2024

May 15, 2024

BUY
$65.98 - $77.09 $3.8 Million - $4.45 Million
57,660 Added 5.98%
1,022,620 $72 Million
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $44.3 Million - $65.6 Million
838,128 Added 660.82%
964,960 $74.5 Million
Q3 2023

Nov 14, 2023

SELL
$67.52 - $89.42 $25,657 - $33,979
-380 Reduced 0.3%
126,832 $8.63 Million
Q2 2023

Aug 14, 2023

BUY
$73.76 - $85.98 $520,598 - $606,846
7,058 Added 5.87%
127,212 $10.4 Million
Q1 2023

May 15, 2023

SELL
$71.62 - $86.62 $204,976 - $247,906
-2,862 Reduced 2.33%
120,154 $8.91 Million
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $7.41 Million - $32.3 Million
91,794 Added 294.0%
123,016 $10.2 Million
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $202,016 - $280,172
-715 Reduced 2.24%
31,222 $8.87 Million
Q2 2022

Aug 15, 2022

BUY
$322.67 - $449.65 $2.78 Million - $3.87 Million
8,604 Added 36.87%
31,937 $11.1 Million
Q1 2022

May 16, 2022

SELL
$353.85 - $487.79 $234,248 - $322,916
-662 Reduced 2.76%
23,333 $10.1 Million
Q4 2021

Feb 14, 2022

SELL
$456.15 - $525.06 $2.95 Million - $3.4 Million
-6,474 Reduced 21.25%
23,995 $12.4 Million
Q3 2021

Nov 15, 2021

SELL
$444.87 - $538.88 $555,642 - $673,061
-1,249 Reduced 3.94%
30,469 $14.8 Million
Q2 2021

Aug 16, 2021

SELL
$387.35 - $450.26 $6.32 Million - $7.35 Million
-16,325 Reduced 33.98%
31,718 $14.3 Million
Q1 2021

May 17, 2021

SELL
$314.62 - $411.0 $1.28 Million - $1.67 Million
-4,057 Reduced 7.79%
48,043 $18.3 Million
Q4 2020

Feb 16, 2021

SELL
$246.9 - $321.87 $91,599 - $119,413
-371 Reduced 0.71%
52,100 $16.5 Million
Q3 2020

Nov 13, 2020

BUY
$232.22 - $282.96 $1.52 Million - $1.85 Million
6,534 Added 14.22%
52,471 $13 Million
Q2 2020

Aug 14, 2020

SELL
$185.43 - $279.56 $33,377 - $50,320
-180 Reduced 0.39%
45,937 $12.1 Million
Q1 2020

May 15, 2020

BUY
$161.17 - $221.51 $1.82 Million - $2.5 Million
11,281 Added 32.38%
46,117 $8.75 Million
Q4 2019

Feb 14, 2020

BUY
$189.68 - $222.09 $1.54 Million - $1.81 Million
8,144 Added 30.51%
34,836 $7.65 Million
Q3 2019

Nov 14, 2019

SELL
$183.56 - $216.72 $12,482 - $14,736
-68 Reduced 0.25%
26,692 $5.22 Million
Q2 2019

Aug 14, 2019

SELL
$188.72 - $215.43 $103,984 - $118,701
-551 Reduced 2.02%
26,760 $5.58 Million
Q1 2019

May 15, 2019

SELL
$136.09 - $200.44 $431,541 - $635,595
-3,171 Reduced 10.4%
27,311 $5.42 Million
Q4 2018

Feb 14, 2019

BUY
$132.75 - $203.8 $408,339 - $626,888
3,076 Added 11.22%
30,482 $4.41 Million
Q3 2018

Nov 14, 2018

SELL
$147.44 - $204.11 $741,033 - $1.03 Million
-5,026 Reduced 15.5%
27,406 $5.59 Million
Q2 2018

Aug 14, 2018

BUY
$144.9 - $165.58 $317,186 - $362,454
2,189 Added 7.24%
32,432 $4.8 Million
Q1 2018

May 14, 2018

BUY
$131.46 - $151.04 $1.15 Million - $1.32 Million
8,722 Added 40.53%
30,243 $4.57 Million
Q4 2017

Feb 13, 2018

BUY
$121.17 - $134.75 $154,370 - $171,671
1,274 Added 6.29%
21,521 $2.79 Million
Q3 2017

Nov 14, 2017

BUY
$113.59 - $123.78 $2.3 Million - $2.51 Million
20,247
20,247 $2.45 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.87B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Snyder Capital Management L P Portfolio

Follow Snyder Capital Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snyder Capital Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Snyder Capital Management L P with notifications on news.